Profile for Japan Patent: 2017145251
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 2017145251
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,623,819 | Aug 22, 2028 | Novartis | VANRAFIA | atrasentan hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
